Lipella Pharma enters $2.64M ATM equity facility with H.C. Wainwright

LIPELLA PHARMACEUTICALS INC.

ATM agreement for up to $2,641,881 of common stock at market prices.
H.C. Wainwright receives 3.0% cash commission on gross proceeds.
Proceeds will be used for working capital and general corporate purposes.
Shares offered under existing effective S-3 shelf registration.
No obligation to sell; company may suspend or terminate at any time.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.